Transport of Alzheimer's Associated Amyloid-β Catalyzed by P-glycoprotein
J. W. McCormick, L. Ammerman, G. Chen, P. D. Vogel, J. G. Wise
Abstract
P-glycoprotein (P-gp) is a critical membrane transporter in the blood brain barrier (BBB) and is implicated in Alzheimers disease (AD). However, previous studies on the ability of P-gp to directly transport the Alzheimers associated amyloid-{beta} (A{beta}) protein have produced contradictory results. Here we use molecular dynamics (MD) simulations, transport substrate accumulation studies in cell culture, and biochemical activity assays to show that P-gp actively transports A{beta}. We observed transport of A{beta}40 and A{beta}42 monomers by P-gp in explicit MD simulations of a putative catalytic cycle. In in vitro assays with P-gp overexpressing cells, we observed enhanced accumulation of fluorescently labeled A{beta}42 in the presence of Tariquidar, a potent P-gp inhibitor. We also showed that A{beta}42 stimulated the ATP hydrolysis activity of isolated P-gp in nanodiscs. Our findings expand the substrate profile of P-gp, and suggest that P-gp may contribute to the onset and progression of AD.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Macropinocytosis of aggregated amyloid-beta and tau requires Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA.
Jordan M Krupa, Manoj Reddy Medapati, … Stephen Pasternak·bioRxiv·Mar 2, 2025
- Butyrate regulates the blood-brain barrier transport and intra-endothelial accumulation of Alzheimers disease Amyloid-beta peptides
Vaishnavi Veerareddy, Zengtao Wang, … Karunya K. Kandimalla·Molecular PharmaceuticsPeer-reviewed·May 21, 2026
- Aquaporin-4 mediated aggregation of Alzheimer's amyloid β-peptide
N. Maroli·bioRxiv·Feb 8, 2023
- Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimer's Disease
L. Wang, G. L. Curran, … K. K. Kandimalla·bioRxiv·Nov 21, 2022
- Substrate Transport is Mediated not only by P-glycoprotein but also by Lipid Penetration
- Exofection as a Therapeutic Modality: Restoring P-gp Activity via Trophoblast-Derived EV in Neuroinflammatory Disorders
Ananth Kumar Kammala, Madhuri Tatiparthy, … Balaji Krishnan·bioRxiv·Apr 6, 2026